Saturday, April 16, 2022

mRNA vaccine for Epstein-Barr Virus enters Phase I trial.


 mRNA vaccine for Epstein-Barr Virus enters Phase I trial.

Visit: https://infectious.pencis.com/
Contact us: infectious@pencis.com

#infectiousdiseases #bacteriology #virology #microbiology #medicine #zikavirus #bacteria #epidemiology #immunology #diphtheria #vaccin #tuberculosis #treatment #infection #virus

No comments:

Post a Comment

From Aid to Impact: Cost-Effective Global Health Aid & Microinsurance Africa #pencis #researchawards

Introduction Development Assistance for Health (DAH) has long served as a major pillar of health financing across Sub-Saharan Africa , part...